Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Parkinson Disease in United States

252 results

Sort By:

Step Up to PD: A Community-based Walking Program for People With Parkinson's Disease

Study ID: NCT06859528
Start Date: 2025-04-01
End Date: 2027-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Community Walking Program

Sponsor

St. Louis University

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease

Study ID: NCT06565195
Start Date: 2024-08-27
End Date: 2029-05-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

108

Intervention / Treatment

To succumb 1

Placebo (aCSF)

Sponsor

Prevail Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Globus Pallidus Stimulation to Treat Insomnia

Study ID: NCT04116996
Start Date: 2019-01-01
End Date: 2029-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

DEEP BRAIN STIMULATION

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia

Study ID: NCT05317390
Start Date: 2022-06-01
End Date: 2028-04-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

DystoniaNet-based diagnosis of isolated dystonia

Sponsor

Massachusetts Eye and Ear Infirmary

Source: clinicaltrials.gov

Share:
Add to list

Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

Study ID: NCT06692920
Start Date: 2024-12-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

DBS stimulation

Sponsor

University of Minnesota

Source: clinicaltrials.gov

Share:
Add to list

High Frequency Light, Sound, and Tactile Stimulation to Improve Motor and Cognitive Deficits in Parkinson's Disease

Study ID: NCT05268887
Start Date: 2022-02-09
End Date: 2027-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

GENUS device (Active Settings)

GENUS device (Sham settings)

Sponsor

Massachusetts Institute of Technology

Source: clinicaltrials.gov

Share:
Add to list

Transplantation of Human iPS Cell-derived Dopaminergic Progenitors (CT1-DAP001) for Parkinson's Disease (Phase I/II)

Study ID: NCT06482268
Start Date: 2024-06-01
End Date: 2028-05
Study Type

Interventional

Study Phase

Phase1

No. of Participants

7

Intervention / Treatment

Human induced pluripotent stem cell-derived dopaminergic progenitors (CT1-DAP001)

Sponsor

University of California, San Diego

Source: clinicaltrials.gov

Share:
Add to list

Balance Tele-Rehab in Parkinson's Disease Parkinson's Disease

Study ID: NCT05680597
Start Date: 2022-09-19
End Date: 2027-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Balance Tele-Rehabilitation Agility Boot Camp (ABC)

Sponsor

Oregon Health and Science University

Source: clinicaltrials.gov

Share:
Add to list

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Study ID: NCT07174310
Start Date: 2025-11-24
End Date: 2031-06-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

900

Intervention / Treatment

Prasinezumab

Placebo

Sponsor

Hoffmann-La Roche

Source: clinicaltrials.gov

Share:
Add to list

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

Study ID: NCT05539196
Start Date: 2023-01-23
End Date: 2029-07-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Exablate Pallidotomy, Unilateral

Sponsor

InSightec

Source: clinicaltrials.gov

Share:
Add to list